The Estimation of Prevalence, Incidence, and Residual Risk of Transfusion-Transmitted Human Hepatitis B Infection from Blood Donated at the Anhui Blood Center, China, from 2009 to 2011

被引:9
|
作者
Li, Wuping [1 ,2 ,3 ]
Gao, Zhan [2 ,3 ]
Yang, Chunhui [2 ,3 ]
Li, Jiahu [4 ]
Li, Ling [4 ]
Lv, Rong [4 ]
Liu, Zhong [2 ,3 ,4 ]
机构
[1] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China
[2] Peking Union Med Coll, Beijing 100021, Peoples R China
[3] Chinese Acad Med Sci, Inst Blood Transfus, Beijing 100730, Peoples R China
[4] Anhui Blood Ctr, Hefei, Anhui, Peoples R China
来源
PLOS ONE | 2013年 / 8卷 / 09期
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; C VIRUS; VIRAL-INFECTIONS; DONORS; IMPACT;
D O I
10.1371/journal.pone.0073472
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: The high prevalence of hepatitis B virus (HBV) among the Chinese population poses a threat to blood safety; however, few studies have examined epidemiological data regarding HBV infection of Chinese blood donors. The present study investigated the demographic characteristics of blood donors at the Anhui blood center in China, the prevalence, incidence, and residual risk (RR) associated with hepatitis B surface antigen (HBsAg) expression in terms of transfusion transmitted HBV (TTHBV) infections. Methods: The demographic characteristics and HBV status of people who donated blood at the Anhui blood center between 2009 and 2011 were retrospectively analyzed. The incidence of HBV was estimated through HBsAg yield approach. The window period model was then used to estimate the RR of TTHBV infection. Results: The typical donor at the Anhui blood center was a first-time volunteer, aged less than 25 years, unmarried, of Han ethnicity, and with an education below high school level. The prevalence of HBV infection among repeat donors, first-time donors, and all donors was 28.9, 127.2 and 82.1 per 100,000, respectively. The incidence estimate was 333.9 per 105 person-years. Using an infectious window period of 59 days, the RR for HBV was estimated to be 1 in 1853 between 2009 and 2011. Conclusions: The incidence and RR of HBV in Chinese blood donors are much higher than those of donors in developed countries. This is because sensitive ELISAs and nucleic acid tests are not available in China. Further work is needed to improve both the safety and availability of blood products in China.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Risk of Hepatitis B, Hepatitis C, and Human Immunodeficiency viruses from Blood Transfusion in Oman
    Al Yahyai, M. S.
    Al Ajmi, H. M.
    Al-Khabori, M.
    Daar, S.
    Zachariah, M.
    TRANSFUSION, 2015, 55 : 194A - 194A
  • [32] ESTIMATION OF INCIDENCE AND RESIDUAL RISK OF TRANSFUSION TRANSMITTED INFECTION FOR HIV, HCV AND HBV IN HONG KONG: 2007-2009
    Tsoi, W. C.
    Lee, C. K.
    Lin, C. K.
    VOX SANGUINIS, 2011, 101 : 83 - 83
  • [33] The estimation of prevalence and risk factors of hepatitis B virus infection among blood donors in Chengdu, China
    Zhong, Li
    Xi, Guangxiang
    Zhang, Lanjiang
    Liu, Shuangli
    Wan, Like
    Yu, Lian
    Zhou, Min
    Zhang, Jie
    He, Yi
    JOURNAL OF MEDICAL VIROLOGY, 2016, 88 (02) : 260 - 267
  • [34] Prevalence of Hepatitis B and C in Donated Blood from the Jazan Region of Saudi Arabia
    Abdullah, Saleh Mohammed
    MALAYSIAN JOURNAL OF MEDICAL SCIENCES, 2013, 20 (02): : 41 - 46
  • [35] Impact of Multiplex PCR in Reducing the Risk of Residual Transfusion-Transmitted Human Immunodeficiency and Hepatitis B and C Viruses in Burkina Faso
    Yooda, Arzouma Paul
    Soubeiga, Serge Theophile
    Nebie, K. Yacouba
    Diarra, Birama
    Sawadogo, Salam
    Ouattara, Abdoul Karim
    Obiri-Yeboah, Dorcas
    Yonli, Albert Theophane
    Tao, Issoufou
    Sorgho, Pegdwende Abel
    Dahourou, Honorine
    Simpore, Jacques
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2018, 10
  • [36] Prevalence of serologic markers for hepatitis B and C viruses in Brazilian blood donors and incidence and residual risk of transfusion transmission of hepatitis C virus
    de Almeida-Neto, Cesar
    Sabino, Ester Cerdeira
    Liu, Jing
    Blatyta, Paula Fraiman
    Mendrone-Junior, Alfredo
    Salles, Nanci Alves
    Leao, Silvana Carneiro
    Wright, David J.
    Basques, Fernando Valadares
    Ferreira, Joao Eduardo
    Busch, Michael P.
    Murphy, Edward L.
    TRANSFUSION, 2013, 53 (04) : 827 - 834
  • [37] Managing the risk of transfusion-transmitted malaria from Australian blood donations: Recommendation of a new screening strategy
    Schenberg, Katia
    Hoad, Veronica C.
    Harley, Robert
    Bentley, Peter
    VOX SANGUINIS, 2024, 119 (09) : 945 - 952
  • [38] Prevalence, incidence and residual risk of transfusion-transmitted hepatitis C virus and human immunodeficiency virus after the implementation of nucleic acid testing in Italy: a 7-year (2009-2015) survey
    Velati, Claudio
    Romano, Luisa
    Piccinini, Vanessa
    Marano, Giuseppe
    Catalano, Liviana
    Pupella, Simonetta
    Facco, Giuseppina
    Pati, Ilaria
    Tosti, Maria Elena
    Vaglio, Stefania
    Grazzini, Giuliano
    Zanetti, Alessandro
    Liumbruno, Giancarlo M.
    BLOOD TRANSFUSION, 2018, 16 (05) : 422 - 432
  • [39] Prevalence, incidence, and residual risk for human immunodeficiency virus among blood donors from 2003 to 2022 in Guangzhou, China
    Xie, Junmou
    Li, Zhongping
    Liang, Haojian
    Huang, Zhijian
    Du, Rongsong
    Gao, Wenbo
    Huang, Boquan
    Liao, Fenfang
    Rong, Xia
    Fu, Yongshui
    Nie, Yongmei
    Liang, Huaqin
    Wang, Hao
    TRANSFUSION, 2024, 64 (11) : 2157 - 2167
  • [40] The incidence window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection
    Kleinman, S
    Busch, MP
    Korelitz, JJ
    Schreiber, GB
    TRANSFUSION MEDICINE REVIEWS, 1997, 11 (03) : 155 - 172